Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00137826
Status:
COMPLETED
Last Update Posted:
2011-12-26
First Post:
2005-08-29
Brief Title:
Bevacizumab Avastin and Erlotinib Tarceva in Previously Treated Mesothelioma
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
03-369
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dana-Farber Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Pasi A Janne MD PhD
Responsible Party Title:
Associate Professor Medicine
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Dana-Farber Cancer Institute
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of Chicago | OTHER |
| Massachusetts General Hospital | OTHER |